Abstract:The treatment of acute promyelocytic leukemia (APL) with all trans retinoic acid (ATRA) has set a model for the differentiation induction-based new therapy. Although a substantial body of data related to ATRA-induced differentiation mechanisms has been obtained, the molecular events down stream of RA receptor complexes remain obscure. With the goal to get further insights into regulatory networks underlying ATRA-induced differentiation in APL, we applied 2DG, MS and cDNA microarray combined with bioinformatics analysis such as self-organizing map(SOM) to profile NB4 cells treated with ATRA over 3 time points (0h, 12h, 48h). Our results showed that cell cycle was arrested and proliferation was suppressed. For instance, ;the Origin recognition complex subunit 3 involved in initiating DNA replication that make the cell switch to S phase was downregulated significantly at protein (67.55 times) and mRNA levels; Breast cancer type 2 susceptibility protein (BRCA2) that can interact with BRAF335 as the checkpoint of G2 / M phase was upregulated while mRNA expression unchanged. Our results showed that the expression of many proteins associated with Ca2+ signal pathway such as IP3 receptor isoform 1 and phospholipase C-β changed upon induction with ATRA, implying that Ca2+ signal pathways may play an important role during ATRA-induced APL cell differentiation. Our results also indicated that the cell apoptosis was inhibited in the process of ATRA-induced differentiation. For example, BFL1, one of the BCL-2 family and the main apoptosis repressor in neutrophils, was upregulated at protein and mRNA levels. BCL2-like13 is one of the BCL-2 families and its overexpression initiated the cell apoptosis pathway by activating caspase-3. It was downregulated at protein level. Our results revealed that the phosphopentose pathway and ribonucleotide synthesis were repressed obviously. The protein expressions of the key enzyme of phosphopentose pathway - Glucose-6-phosphate dehydrogenase and rate-limiting enzyme of purine nucleotide de novo synthesis - AICAR methylferase and adenylosuccinate synthetase were all downregulated remarkably. Moreover, the protein expression of nitricoxide synthase 2A was upregulated 236 times after 12 hours of treatment with ATRA. The dramatic changes imply that the effect of NO on the differentiation induced by ATRA deserves more investigation. In brief, the data presented above indicated the expression of a large number of genes and proteins is modulated upon effect of ATRA during ATRA-induced APL cell differentiation, resulting in a complex and well-organized network to ensured cell reprogramming.

The Ubiquitin-Proteasome Pathway Plays Essential Roles In Atra-Induced Leukemia Cells G(0)/G(1) Phase Arrest And Transition Into Granulocytic Differentiation

Research Advance on the Role of Ubiquitin Proteasome Pathway In Acute Promyelocytic Leukemia——Rewiew

Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.

A Genomic and Proteomic Research for the Regulatory Networks of Atra-Induced Differentiation of Acute Promyelocytic Leukemia Cells

Retinoic Acid Induces Leukemia Cell G(1) Arrest and Transition into Differentiation by Inhibiting Cyclin-Dependent Kinase-Activating Kinase Binding and Phosphorylation of Pml/Rar Alpha

Deubiquitinase USP48 Promotes ATRA-induced Granulocytic Differentiation of Acute Promyelocytic Leukemia Cells.

All-trans retinoic acid induces autophagic degradation of ubiquitin-like modifier activating enzyme 3 in acute promyelocytic leukemia cells.

Nutlin-1 Strengthened Anti-Proliferation and Differentiation-Inducing Activity of ATRA in ATRA-treated P-Glycoprotein Deregulated Human Myelocytic Leukemia Cells.

Comparative Proteomic Analysis of All-Trans-retinoic Acid Treatment Reveals Systematic Posttranscriptional Control Mechanisms in Acute Promyelocytic Leukemia

Gene Expression Networks Underlying Retinoic Acid–induced Differentiation of Acute Promyelocytic Leukemia Cells

Mechanisms Ofall-Trans Retinoic Acid-Induced Differentiation of Acute Promyelocytic Leukemia Cells

Enzastaurin Enhances ATRA-induced Differentiation of Acute Myeloid Leukemia Cells.

Role of cardiolipins, mitochondria, and autophagy in the differentiation process activated by all-trans retinoic acid in acute promyelocytic leukemia

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: in Vitro and in Vivo Studies

Restoration Of Ccaat Enhancer Binding Protein Alpha P42 Overcomes Myeloid Differentiation Block And All-Trans Retinoic Acid Resistance In Human Acute Promyelocytic Leukemia Nb4-R1 Cells

Treatment of Acute Promyelocytic Leukemia with ATRA and As2O3: a Model of Molecular Target-Based Cancer Therapy.

Induced Lineage Promiscuity Undermines the Efficiency of All-Trans-retinoid-acid-induced Differentiation of Acute Myeloid Leukemia

Data from Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-<i>Trans</i>-Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis

Activation Of G0s2 Is Coordinated By Recruitment Of Pml/Rar Alpha And C/Ebp Epsilon To Its Promoter During Atra-Induced Apl Differentiation

ATRA-induced partially differentiated leukemia cells retain de-differentiation potential

Distinguishing between cancer cell differentiation and resistance induced by all-trans retinoic acid using transcriptional profiles and functional pathway analysis.